VAERS Explorer
Back to explore

Report #2854214

Received Aug 15, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
—
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
PNC21PNEUMO (CAPVAXIVE)MERCK & CO. INC.UNK——

Symptoms (2)

No adverse eventProduct administered to patient of inappropriate age

Symptom narrative

FBE calling regarding a potential AE on behalf of an HCP. Caller stated that the facility might have purchased adult CAPVAXIVE vaccine and it may have been given it to pediatric patient. No further information was available from the FBE upon probing.; No adverse event; This spontaneous report was received from a physician and refers to a child patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown date, the patient was vaccinated with Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE), administered for prophylaxis (dose, lot #, expiration date, route of administration and anatomical site of injection were not reported). It was reported that the facility might have purchased an adult vaccine, and it may have been given to a pediatric patient (Product administered to patient of inappropriate age). No further information was available, no additional adverse event (No adverse event).